1 HIV Infection of the Nervous System Neuropsychological Factors
2 How Does HIV Affect the Nervous System? HIV easily crosses the blood-brain brain barrier Dave R, Pomerantz RJ. (2005). HIV neuropathogenesis: persistent infection, persistent questions. Science & Medicine.
3 How Does HIV Affect the Nervous System? General immunosuppression can lead to: Opportunistic Infections Fungal (Cryptococcal Meningitis) Parasitic (Toxoplasmosis) Viral (Progressive Multifocal Leukoencephalopathy) HIV-Related Tumors
4 How Does HIV Affect the Nervous System? Primary HIV Disease can lead to: AIDS Dementia Complex (brain) Vacuolar Myelopathy (spinal cord) Peripheral Neuropathy (nerve) Meningitis (acute and chronic)
5 How Does HIV Affect the Nervous System? HIV indirectly destroys cells in the nervous system Kaul, Garden & Lipton (2001). Pathways to neuronal injury and apoptosis in HIVassociated dementia. Nature 410,
6 How Does HIV Affect the Nervous System? 10-15% 15% of AIDS patients present with neurologic symptoms only 35-50% 50% of AIDS patients have neurologic symptoms during life 1, % have neuropathologic abnormalities at death 3 1) Brouwman et al, Neurology ; 50: ) McArthur J Neuroimmunol 2004; 157 : ) Vago et al., AIDS. 2002;16:
7 Progression of HIV Infection of the Nervous System HIV neg HIV positive, but otherwise asymptomatic Constitutional Symptoms & Severe Immunosuppression, but no OIs AIDS Acute Chronic Meningitis Schematic diagram of HIV-related diseases that affect central nervous system (solid border) and peripheral nervous system (dotted border). Adapted from Johnson et al., 1988.
8 Progression of HIV Infection of the Nervous System HIV neg HIV positive, but otherwise asymptomatic Constitutional Symptoms & Severe Immunosuppression, but no OIs AIDS Acute Chronic Meningitis HIV-Associated Neurocognitive Disorders Schematic diagram of HIV-related diseases that affect central nervous system (solid border) and peripheral nervous system (dotted border). Adapted from Johnson et al., 1988.
9 HIV-associated Neurocognitive Disorders (HAND) (HIV-1-Associated Dementia) (HIV-associated Cognitive/Motor Complex) (HIV-associated Mild Neurocognitive Disorder) (Asymptomatic Neurocognitive Impairment) (HIV-Associated Mild Cognitive/Motor Disorder) (AIDS Dementia Complex) Patients with the AIDS dementia complex present with a variable, yet characteristic, constellation of abnormalities in cognitive, motor, and behavioral function. Perhaps the salient aspects of the disorder are the slowing and loss of precision in both mentation and motor control.. These patients often lose interest in their work as well as in their social and recreational activities. (Price et al., 1988)
10 HIV-Associated Neurocognitive Disorders (HAND) HIV dementia is generally considered a subcortical dementia.
11 HIV-Associated Neurocognitive Disorders (HAND) HIV dementia is generally considered a subcortical dementia. HIV dementia symptoms are more associated with motor slowing and loss of executive control than with language and memory disturbance.
12 HIV-Associated Neurocognitive Disorders (HAND) HIV dementia is generally considered a subcortical dementia. HIV dementia symptoms are more associated with motor slowing and loss of executive control than with language and memory disturbance. Later stage illness affects both cortical and subcortical regions and may affect memory.
13 HIV-Associated Neurocognitive Disorders (HAND) Asymptomatic Neurocognitive Impairment (ANI) Mild Neurocognitive Disorder (MND) HIV-Associated Dementia (HAD) Neurocognitive Impairment (Neuropsychological Testing) Mild Mild Moderate Functional Impairment (Activities of Daily Living) None > Mild > Moderate Woods, SP, et. al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. Journal of Clinical and Experimental Neuropsychology, 2004,26, p Antinori A, et al. Neurology 2007; 69;
14 Assessment of HAND Behavioral Observations
15 Assessment of HAND Behavioral Observations Acquired abnormality
16 Assessment of HAND Behavioral Observations Acquired abnormality Change in normal Activities of Daily Living
17 Assessment of HAND Behavioral Observations Acquired abnormality Change in normal Activities of Daily Living Change in mood or normal social relationships
18 Assessment of HAND Behavioral Observations Acquired abnormality Change in normal Activities of Daily Living Change in mood or normal social relationships Rule out other medical conditions
19 HIV- Associated Neurocognitive Disorder Other medical conditions HIV-Associated Neurocognitive Disorders may share symptoms with: Mood disorders Drug and alcohol abuse Mania and psychosis Other infections and neurologic problems Oversedation with medications commonly given for sleep, mood problems and other disorders
20 Assessment of HAND Behavioral Observations Acquired abnormality Change in normal Activities of Daily Living Change in mood or normal social relationships Rule out other medical conditions Neuropsychological (Cognitive) Tests
21 Neuropsychological Tests Functional Domains Attention and Concentration Gross and Fine Motor Skills Verbal and Nonverbal Memory Language Skills Visuoperceptual Skills Executive Skills/Higher Order Reasoning
22 Neuropsychological Tests Functional Domains Impaired in HIV Attention and Concentration Gross and Fine Motor Skills Verbal and Nonverbal Memory Language Skills Visuoperceptual Skills Executive Skills/Higher Order Reasoning
23 Neuropsychological Tests Mini-mental status exam lacks sensitivity (no measures of psychomotor change) Standard psychological measures (personality, aptitude, achievement) are helpful, but lack specificity
24 Core Cognitive Impairments Cognitive and motor slowing Reaction time tests Motor measures Poor divided attention / executive skills Trail Making test Stroop Color Interference Memory (usual in later stages)
25 Trail-Making Part B
26 Stroop Color Interference Test
27 Grooved Pegboard
28 Neuropsychological Assessment of HIV Dementia Neuropsychological tests are used to: Identify specific patterns of cognitive impairment that are associated with HIV dementia. Potentially identify different subtypes of HIV dementia. Track the progression of cognitive changes typically seen in HIV dementia.
29 Progression of Untreated HIV Infection Simplified course of untreated HIV infection; there is considerable variability across individuals CD4+ T Lymphocyte count (cells/mm³) ---- HIV RNA copies per ml of plasma
30 Changes in Performance on Trails B Before and After HIV-1 1 Seroconversion
31 Changes in Performance on Trails B Before and After Diagnosis of AIDS
32 Stage of HIV Disease and Neuropsychological Test Performance Decline on neuropsychological testing is closely linked to general systemic illness. In general, observable cognitive changes are not seen during early, medically asymptomatic, stages of HIV disease. Data from HIV-positive subjects with known dates of seroconversion suggest that there is no relationship between duration of HIV seropositivity and neuropsychological decline.
33 Incidence and Prevalence of HIV-Associated Neurocognitive Disorders (HAND) Prior to HAART (before 1995) After HAART (1996+) New cases of dementia occurred at a rate of 7% per year Incidence of all types of primary HIV neuropsychiatric disease have decreased dramatically 15-40% of individuals developed dementia prior to death Median survival after dementia was 6 months Incidence of cognitive impairment has been halved and dementia is rare With proper treatment, HIV is considered a chronic disease
34 Declines in Incidence of HIV-associated CNS Disease in the HAART Era
35 HAND in the Era of HAART Although incidence of HIV dementia has decreased dramatically, milder forms of cognitive impairment have increased. After over 25 years of research, the specific triggers for HAND remain unknown. Improved survival means that more individuals with HAND must learn to cope with the disabling effects of impaired cognition.
36 HAND in the Era of HAART Effective treatments for HAND are not yet available. Individuals who are treated with HAART shortly after the first symptoms of cognitive impairment appear may show dramatic improvement. Individuals who have shown symptoms of cognitive impairment for a while do not seem responsive to treatment.
37 HIV Neuropathogenesis Sustained CNS inflammation
38 HIV indirectly destroys cells in the nervous system Kaul, Garden & Lipton (2001). Pathways to neuronal injury and apoptosis in HIVassociated dementia. Nature 410,
39 HIV Neuropathogenesis Sustained CNS inflammation Accelerated vascular disease
42 Brain deposition of beta-amyloid is a common feature in HIV+ patients (age years) (Green et al AIDS 2005) AD HIV Amyloid is increased in diffuse non-neuritic plaques in HIV+ brains An increase in diffuse plaques suggest early aging with HIV infection and may be enough to cause cognitive impairment HIV HIV
44 Demographic Risk Factors Individuals with less education are at greater risk Brain reserve capacity Socioeconomic status and access to health care Early studies suggested that older individuals may be at greater risk
45 HIV and Aging In recent studies of HIV and aging, the best predictors of poorer cognitive functioning were markers of early cerebrovascular disease, not HIV serostatus. In the post-haart era, it appears that HIV infection may not be a particularly important predictor of cognitive functioning, at least among individuals with access to medical care and appropriate medications. Primary risk factors for cognitive impairment in older HIV- infected individuals are the same medical conditions that are associated with normal aging. (Becker, 2009; Sacktor, 2009)
46 Genetic Susceptibility Several genetic loci have been tentatively associated with changes in cognitive functioning. Genetic studies have been difficult to replicate. Genetic factors associated with cognitive impairments may be similar across dementing disorders (HIV, Alzheimers, etc.). Predictive power of genetic profiles has not been particularly strong.
47 Medical Treatments for HIV Dementia Does HAART penetrate the blood-brain brain-barrier? barrier? Many types of HAART do not easily cross into the brain in laboratory studies However, HIV-infected individuals may show increased permeability of the blood-brain brain-barrierbarrier
48 Medical Treatments for HIV Dementia High dose zidovudine (AZT) (ACTG 005) Nimodipine antagonist) Memantine Selegiline (ACTG 162; Calcium channel Memantine (ACTG 301; NMDA antagonist) repair) (ACTG A5090; antioxidant/cell Highly Active Antiretroviral Therapies (HAART)
49 Medical Treatments for HIV Dementia HAART usually reduces viral load both in the periphery and in the CNS. Reduction of viral load in the CNS is associated with reduced cognitive symptoms. (Ellis et al., 2003) Individuals with stable viral load do not show increased risk for cognitive decline, even after 5 years of monitoring. (Cole et al., 2007)
50 What are the Practical Implications of These Research Findings? Changes in brain metabolism may be present even during early stages of HIV infection. When viral load is adequately controlled, these changes in brain metabolism do not affect day-to to-day functioning, motor skills, or higher order reasoning even though very subtle changes may appear on cognitive testing.
51 What are the Practical Implications of These Research Findings? With heightened viral load and immunosuppression, HIV may cause a potentially reversible inflammation of brain tissue. With sustained viral replication, HIV may cause permanent cell death. Even with uncontrolled viral load and immunosuppression, many people do not develop HIV dementia.
52 Goals of Current Research Identify risk factors for developing dementia Identify biological mechanisms that lead to cell death and dementia Establish effective screening tools to identify early stage dementia Develop medical interventions that will reverse the symptoms of dementia before permanent damage occurs
Cognitive Impairment LPT Gondar Mental Health Group www.le.ac.uk Areas to be covered Causes of cognitive impairment Delirium Definition and causes Clinical features Management principles Dementia Common
Impact of HIV on the Brain and Cognition Eileen Martin, PhD Professor of Psychiatry and Neurology University of Illinois at Chicago Supported by HHS R01 DA12828 Learning Objectives At the conclusion of
Chapter 30 Caring for Persons With Confusion and Dementia Changes in the Brain Changes in the brain and nervous system occur with aging. Certain diseases affect the brain. Changes in the brain can affect
: It s Not Just Forgetfulness Alzheimer s Disease Research 2 Alzheimer s disease affects people s memories, but it involves far more than simple forgetfulness. It is a progressive, degenerative, and incurable
Alzheimer s Disease Alzheimer s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks. In most
Central nervous system By Dr. Mohsen Dashti Clinical Medicine & Pathology 316 7 th Lecture Lecture outline Review of structure & function. Symptoms, signs & tests. Specific diseases. Review of structure
Update on Alzheimer s Disease Samir F. Atweh Professor and Chairman Department of Neurology American University of Beirut Alzheimer s Disease The most common form of dementia in the elderly Age related
Objectives: 1. For multiple sclerosis, describe the pathogenesis, type and location of pathological changes; signs and symptoms; diagnostic criteria including CSF findings; and course of disease: 2. Know
What is dementia? Dementia is an overall term for a set of symptoms that are caused by disorders affecting the brain. Symptoms may include memory loss and difficulties with thinking, problem-solving or
ALZHEIMER S DISEASE Clinical definition 1. Dementia is a chronic progressive, degenerative, cerebral disorder; 2. It affects higher cortical functions including memory, thinking and orientation; 3. Alzheimer
Alzheimer s disease in Individuals with Down Syndrome Janis McGillick, MSW, LNHA Dolan Memory Care Homes Director of Community Engagements Formerly with the Alzheimer s Association St. Louis Board Member-
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Assessment, Diagnosis and Treatment of HIV Associated Neurocognitive Disorder (HAND) Christine Yuodelis-Flores, MD Aug 15, 2013 Differential diagnosis: conditions
Dementia DEMENTIA what is it? Umbrella term that describes a group of symptoms, it is not a specific disease. There are around 100 types of dementia. Dementia is a syndrome due to disease of the brain,
Psychology Works Fact Sheet: Cognitive Disorders and Dementia What is cognition? Cognition is the ability of your brain to think, to process and store information, and to solve problems. Cognition is a
Neuropsychology Primer for the LTC Underwriter Geoffrey Tremont, Ph.D., ABPP-CN Rhode Island Hospital & The Warren Alpert Medical School of Brown University Outline of Talk Definition of Neuropsychology
Thinking, Memory and Parkinson s Disease Benzi M. Kluger M.D., M.S. Director, Movement Disorders Center Associate Professor of Neurology & Psychiatry University of Colorado OUTLINE I. Defining Terminology
Parallel Issues, Behavioral Issues and Care Provider Struggles C L A I R E B R A N N A N M O B I L E C L A S S E S A N D C O N S U L T I N G A P R I L 1 0 T H, 2 0 1 5 An Aging Population The number of
Vascular dementia (VaD) is defined as permanent cognitive impairment produced by vascular damage to the brain. Although old textbooks, i.e., prior to 1980, suggested that most dementia is produced by strokes,
Page 1 of 5 Memory Loss and Dementia Many people find that they become more forgetful as they become older - this is common and is often not due to dementia. Illnesses such as depression and an underactive
Diabetes Mellitus and Dementia Andrea Shelton & Adena Zadourian Abstract Diabetes mellitus increases the risk for developing dementia...but there is inconsistency with the subtypes of dementia Diabetes
Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault email@example.com Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late
American Epilepsy Society 1 Epilepsy 101 for nurses has been developed by the American Epilepsy Society to prepare professional nurses to understand the general issues, concerns and needs of people with
Primary Endpoints in Alzheimer s Dementia Dr. Karl Broich Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee 38, D-53175 Bonn Germany Critique on Regulatory Decisions in
Dementia: Diagnostic Evaluation and Medical Treatment of Cognitive Dysfunction Paul Mulhausen, MD University of Iowa Carver College of Medicine May 17, 2013 Learning Objectives 1 Apply standard diagnostic
Health Maintenance of the Dementia Patient RL Bender II MD July 29th, 2016 Iowa City, Iowa Disclosure Statement I, Robert Bender II MD do not have any financial interests or relationships with any manufacturers
What is MS? MS is a chronic, often disabling disease that affects the central nervous system (CNS). The CNS consists of the brain, spinal cord and the optic nerves. The nerve fibers of the CNS are surrounded
Internal Use Only:Differential Diagnosis.64518.Apr2015. Diagnosing dementia and the caregiver role Kristin Kahle Wrobleski, Ph.D., HSPP National Alliance for Caregiving March 21 st, 2016 Washington, D.C.
The scientific and regulatory approaches to facilitating disease-modifying drug development and registration in a global environment Thomas Blaettler On behalf of the EFPIA Working Group 24-25 November
Current progress towards new treatments & preventions for dementia Dementia 2020 Conference April 12 th 2016 Simon Ridley PhD Director of Research Alzheimer s Research UK Some challenges to researching
Understanding Alzheimer s Disease Lora, diagnosed in 2004, with her daughter, Jill. What Is Alzheimer s Disease? Alzheimer s disease is a neurologic disorder that affects the brain. It causes dementia.
The impact of Alzheimer s disease Ron Petersen, MD, PhD, is Director of the Mayo Alzheimer's Disease Research Center. 2 Typical changes Typical age-related changes involve: Making a bad decision once in
1 The Inductive Psychoplasty (A Psychophysical Medicine) The Inductive Psychoplasty is a psychophysical treatment technique; comprised with the clinical hypnosis, physiotherapy and modern medicines. It
Effects of Memantine in Autism Amy Dixit, PGY-1 Erin Stenson, PGY-1 March 27, 2012 Key Features in Autism Impairment in reciprocal social interactions Poor eye contact, failure to develop peer relationships,
Case report Cerebral venous thrombosis in an HIV infected patient Ioana Cociasu MD Prof. Bogdan O. Popescu, MD, PhD Colentina Clinical Hospital, Neurology Department History of present illness caucasian
Chapter 48 Glossary of HIV/AIDS-Related Terms acquired immunodeficiency syndrome (AIDS): A disease of the body s immune system caused by the human immunodeficiency virus (HIV). AIDS is characterized by
12 LUPUS and the Brain LUPUSUK 2015 LUPUS and the Brain This factsheet endeavours to answer some of the many questions asked regarding lupus and the brain. Doctors throughout the world are now recognising
The Most Feared Terminal Disease: Alzheimer s Presented by Terry Lemerond What exactly is Alzheimer s Disease? Progressive and fatal brain disease brain cells destroyed memory loss problems with thinking
Neuroimaging Biomarkers in HIV Infection: Report of Working Group 4 J.T. Becker (Pittsburgh, USA) L.G. Epstein (Chicago, USA) NIMH/NINDS Consensus Meeting 13 June 2005 Objectives for Neuroimaging Markers
CNS og HIV Isolation of HTLV-III from CerebrospinalFluid and Neural Tissues of Patients withneurologicalsymptoms Relatedto Acquired Immunodeficiency Syndrome Ho D et al: New England Journal of Medicine.
Supplemental Table 1 Studies Considered in Our Review Study Sample Follow up assessments Domains and tests Main results Moorhead 20 BD I Performance IQ: Wechsler et al. (2007) 7 & follow up after 4 Abbreviated
Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn Director of Dementia Education Mental Illness Research, Education, and Clinical Center (MIRECC) VA Palo Alto Health Care System Clinical
General Summary: - Marijuana use appears to have a significant effect on adolescents brain structure and development. In particular, heavy marijuana use is associated with attention, memory, and planning
Understanding Cognitive Disorders Developed by DATA of Rhode Island through a special grant from the RI Department of Human Services Q: What are cognitive disorders? (problem with memory, attention, etc.)
IDENTIFYING AND DEVELOPING STRATEGIES FOR IMPROVING HIV MEDICATION ADHERENCE Carlie Arbaugh Second Year Medical Student Stanford University Office of Community Health Valley Fellowship Summer 2016 Edison
!" " Age-Related Patterns in Health and Disease Mortality Rates and Causes of Death Morbidity Rates, Illness, and Disability Age-Related Patterns in Health and Disease Mortality Rates and Causes of Death
Chapter 8: Late Adulthood Module 8.1 Physical Development in Late Adulthood 4/23/2009 1 GERONTOLOGISTS Specialists who study aging Late adulthood as a period of considerable diversity in which people change
GERONTOLOGISTS Chapter 8: Late Adulthood Specialists who study aging Late adulthood as a period of considerable diversity in which people change Growth in some areas, decline in others Module 8.1 Physical
Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Diagnosis of Dementia : DSM-IV criteria Loss of memory and one or more other cognitive abilities Aphasia Apraxia Agnosia
Dementia & Depression: What s the difference? Kesstan Blandin, PhD Dartmouth Centers for Health & Aging Lebanon NH Kesstan.firstname.lastname@example.org Learning Objectives After the program, participants will
Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate
1 Alzheimer Disease (AD) 2 Alzheimer's disease is a progressive degenerative disease that attacks the brain and results in impaired memory, thinking and behavior. It was first described by Dr. Alois Alzheimer
THE 36-HOUR DAY HOW WE CARE Peter V. Rabins Department of Psychiatry Johns Hopkins School of Medicine Dementia Syndrome (Neurocognitive Disorder) Declines in 2 or more cognitive capacities resulting in
Dementia Recognition and Diagnosis in Primary Care The Toolkit That You Really Wanted Birmingham and Solihull Mental Health Foundation NHS Trust Dr Peter Bentham Memory Assessment Service (MAS) Assessment
COGNITIVE AND PHYSICAL DEVELOPMENT IN HIV POSITIVE ADOLESCENTS DR. MARNIE VUJOVIC: CLINICAL PSYCHOLOGIST COGNITIVE AND PHYSICAL DEVELOPMENT IN HIV POSITIVE ADOLESCENTS ADOLESCENCE: AN OVERVIEW ADOLESCENCE
FREQUENCY OF DELIRIUM Delirium is abrupt onset confusion produced by medical problems or drug toxicity. The term comes from Latin de lira or out of the track and this common clinical entity is frequently
American Epilepsy Society 1 The way epilepsy is manifested and the manner in which it affects a person s life can vary for many reasons. The experience of having epilepsy is different from one person to
Mental Health and Neurocognitive Screening Milton L. Wainberg, M.D. Associate Professor of Clinical Psychiatry Columbia University email@example.com ACTHIV Conference Denver April 8, 2011 Learning Objective
Medical Necessity Criteria for Blue Shield of California Members January 1, 2015 Human Affairs International of California (HAI-CA) reviews and determines medical necessity for Blue Shield of California
DEMENTIA 12 Background on Alzheimer s Disease About Dementia Dementia is a general term for a group of brain disorders, of which Alzheimer s disease is the most common. Alzheimer s disease accounts for
Cognitive Function and Ovarian Cancer Erin G. Holker, Ph.D., ABPP Chemobrain A controversial term, originated when women treated for breast cancer noticed mental fogginess Not specific to the effects of
Cognitive Impairment Patient Information Sheet What is dementia? Dementia is a term used to describe the loss of mental function. Memory loss is its most common symptom. Patients can have problems with
Hashimoto's Encephalopathy by Adult Down Syndrome Clinic on Tuesday, June 29, 2010 Hashimoto s Encephalopathy Brian Chicoine, MD Adult Down Syndrome Center What is Hashimoto s Encephalopathy? Hashimoto
Dementia Definition Dementia (or Major Neurocognitive Disorder) is a syndrome characterized by a significant decline from a person s prior baseline in one or more cognitive domainscomplex attention, executive
Cognitive Impairment in Older Adults: Identification and Clinical Implications This presentation was delivered by Valerie T. Cotter, Director of the Adult Health and Gerontology Nurse Practitioner Programs,
MEMORY LOSS: SCIENCE AND THE SEARCH FOR A CURE Dr. Robert Cohen, PsyD, ABPP Director of Neuropsychology, Compass Research Board Certified in Rehabilitation Psychology American Board of Professional Psychology
Effects of hypoglycemia on brain Ji Hyun Kim Department of Neurology Korea University College of Medicine Glucose and brain The brain is dependent on glucose as its principal fuel Interruption of glucose
The Biochemistry of Alzheimer s Disease K A R A B A L D W I N What is Alzheimer s Disease? 2 A progressive brain disorder that damages and destroys brain cells Leads to memory loss and changes in brain
UPDATES TO NEUROCOGNITIVE DISORDERS IN DSM-5 and DSM-5 DESK REFERENCE UPDATED 10-18-13 SUMMARY: These coding changes ensure that insurance reimbursement can be obtained when the specifier With behavioral
Why do some groups have increased risk for Alzheimer s Disease? Carey E. Gleason, PhD Associate Professor, Geriatrics University of Wisconsin, Madison June 14, 2016 6/27/2016 University of Wisconsin Madison
THE JOURNEY OF ADULTHOOD Barbara R. Bjorklund Chapter 3 HEALTH AND HEALTH DISORDERS Mortality Rates and Causes of Death Morbidity rates, illness, and disability Specific diseases Mental disorders Individual
RISK FACTORS FOR DEMENTIA What are risk factors? For some diseases a definite cause is known. This is especially true for infections like measles, malaria or flu. However the situation is more complicated
Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression
1 11April 2014 ABA CoLAP Senior Lawyer Assistance Committee Working Paper on Cognitive Impairment and Cognitive Decline Introduction CoLAP, the American Bar Association s Commission on Lawyer Assistance
Perspectives on Statins and Cognitive Impairment Vera Bittner, MD, MSPH, FNLA Professor of Medicine Section Head, Preventive Cardiology Division of Cardiovascular Disease University of Alabama at Birmingham
OLLI Course: Dr Jeffrey N. Keller Director, Institute for Dementia Research and Prevention Director, Alzheimer Disease Cooperative Study Site Edward G. Schlieder/Hibernia National Bank Chair Professor,
Overview By Mayo Clinic Staff Epilepsy is a central nervous system disorder (neurological disorder) in which nerve cell activity in the brain becomes disrupted, causing seizures or periods of unusual behavior,
CURRICULUM ON NEUROLOGY INTERNAL MEDICINE RESIDENCY PROGRAM Faculty representatives: Robert Hughes MD, Suzanne Brandenburg MD Revision date: November 1, 2006 I. Educational Purpose and Goals The purpose